Allopregnanolone and neuroinflammation: a focus on multiple sclerosis
Open accessAbstract
The progesterone derivative allopregnanolone (ALLO) is one of the most widely studied compounds among neurosteroids. Through interactions with GABA-A receptors expressed by neurons and glial cells, ALLO has been shown to affect diverse aspects of neural cell physiology, including cell proliferation and survival, migration, and gene expression. Recent data point to important roles for ALLO in different neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis (MS). Dysregulation in ALLO biosynthesis pathways has been reported in brain tissue from MS patients as well as in the central nervous system (CNS) tissue derived from MS animal models. Administration of ALLO has been shown to ameliorate neurobehavioral deficits together with neuropathology and inflammation in the CNS of animals with autoimmune demyelination. These findings are in line with previous reports indicating growth- and differentiation-promoting actions of ALLO on neurons and glial cells as well as its neuroprotective effects in the context of other CNS diseases. Nonetheless, these findings have also raised the possibility that ALLO might influence leukocyte biology and associated neuroinflammatory mechanisms independent of its neuroregenerative properties. Herein, we review the current knowledge regarding the role of ALLO in the pathogenesis of MS, and discuss the potential cellular and molecular pathways that might be influenced by ALLO in the context of disease.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Allopregnanolone is beneficial for type C Niemann-Pick disease, Alzheimer's disease, and multiple sclerosis based on preclinical studies in animal models.
“Allopregnanolone is beneficial for type C Niemann-Pick disease, AD, and MS based on preclinical studies in animal models (443).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [443]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149 · see citing works
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724 · see citing works
Papadopoulos, V., Baraldi, M., Guilarte, T. R., Knudsen, T. B., Lacapère, J.-J., Lindemann, P., Norenberg, M. D., Nutt, D., Weizman, A., Zhang, M.-R., et al. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.06.005 · Cited by 1,389 · see citing works
Paul, S. M., & Purdy, R. H. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.6.1347506 · Cited by 1,328 · see citing works
Neurosteroids: endogenous regulators of the GABAA receptor
Belelli, D., & Lambert, J. J. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1703 · Cited by 1,159 · see citing works
New concepts in the immunopathogenesis of multiple sclerosis
Hemmer, B., Archelos, J., & Hartung, H. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn784 · Cited by 605 · see citing works
Neurosteroids: biochemistry and clinical significance
Mellon, S. H., & Griffin, L. D. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00503-3 · Cited by 538 · see citing works
Inhibitory role for GABA in autoimmune inflammation
Bhat, R., Axtell, R., Mitra, A., Miranda, M., Lock, C., Tsien, R. W., & Steinman, L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915139107 · Cited by 509 · see citing works
Will the real multiple sclerosis please stand up?
Stys, P. K., Zamponi, G. W., van Minnen, J., & Geurts, J. J. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3275 · Cited by 475 · see citing works
Rone, M. B., Fan, J., & Papadopoulos, V. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.03.001 · Cited by 399 · see citing works
Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone
Griffin, L. D., Gong, W., Verot, L., & Mellon, S. H. (2004) · Nature Medicine · doi:10.1038/nm1073 · Cited by 395 · see citing works
Djebaı̈li, M., Guo, Q., Pettus, E. H., Hoffman, S. W., & Stein, D. G. (2005) · Journal of Neurotrauma · doi:10.1089/neu.2005.22.106 · Cited by 387 · see citing works
Paul, S. M., & Purdy, R. H. (1992) · PubMed · Cited by 384 · see citing works
Venneti, S., Lopresti, B. J., & Wiley, C. A. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.10.002 · Cited by 373 · see citing works
Reactive Astrocytes Overexpress TSPO and Are Detected by TSPO Positron Emission Tomography Imaging
Lavisse, S., Guillermier, M., Hérard, A., Petit, F., Delahaye, M., Camp, N. V., Haim, L. B., Lebon, V., Rémy, P., Dollé, F., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1487-12.2012 · Cited by 362 · see citing works
Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury
HE, J., EVANS, C., Hoffman, S. D., Oyesiku, N. M., & Stein, D. G. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.06.008 · Cited by 332 · see citing works
Astrocytes are GABAergic cells that modulate microglial activity
Lee, M., Schwab, C., & McGeer, P. L. (2010) · Glia · doi:10.1002/glia.21087 · Cited by 321 · see citing works
Ghoumari, A. M., Ibanez, C., El‐Etr, M., Leclerc, P., Eychenne, B., O’Malley, B. W., Baulieu, E. E., & Schumacher, M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01881.x · Cited by 291 · see citing works
Moscarello, M. A., Mastronardi, F. G., & Wood, D. D. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9144-5 · Cited by 264 · see citing works
Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease
Wang, J. M., Singh, C., Liu, L., Irwin, R. W., Chen, S., Chung, E. J., Thompson, R. F., & Brinton, R. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001422107 · Cited by 263 · see citing works
Wang, J. M., Johnston, P. B., Ball, B. G., & Brinton, R. D. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4520-04.2005 · Cited by 261 · see citing works
Impaired neurosteroid synthesis in multiple sclerosis
Noorbakhsh, F., Ellestad, K. K., Maingat, F. G., Warren, K. G., Han, M. H., Steinman, L., Baker, G. B., & Power, C. (2011) · Brain · doi:10.1093/brain/awr200 · Cited by 230 · see citing works
Self-citationCorreale, J. D., Arias, M., & Gilmore, W. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3365 · Cited by 229 · see citing works
Microglia and multiple sclerosis
Jack, C., Ruffini, F., Bar-Or, A., & Antel, J. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20482 · Cited by 205 · see citing works
Neurosteroids as modulators of neurogenesis and neuronal survival
Charalampopoulos, I., Remboutsika, E., Margioris, A. N., & Gravanis, A. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.07.004 · Cited by 201 · see citing works
The innate immune system in demyelinating disease
Mayo, L., Quintana, F. J., & Weiner, H. L. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01135.x · Cited by 184 · see citing works
Sayeed, I., Guo, Q., Hoffman, S. W., & Stein, D. G. (2006) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2005.12.011 · Cited by 175 · see citing works
GABAA receptors mediate inhibition of T cell responses
Tian, J., Chau, C. H., Hales, T. G., & Kaufman, D. L. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00264-1 · Cited by 165 · see citing works
Neurosteroids as regenerative agents in the brain: therapeutic implications
Brinton, R. D. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.31 · Cited by 164 · see citing works
Progesterone increases oligodendroglial cell proliferation in rat cerebellar slice cultures
Ghoumari, A. M., Baulieu, E. E., & Schumacher, M. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.05.023 · Cited by 161 · see citing works
Ishrat, T., Sayeed, I., Atif, F., Hua, F., & Stein, D. G. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.08.023 · Cited by 159 · see citing works
A TSPO ligand is protective in a mouse model of multiple sclerosis
Daugherty, D. J., Selvaraj, V., Chechneva, O. V., Liu, X., Pleasure, D., & Deng, W. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202124 · Cited by 158 · see citing works
Oligodendrocytes and the early multiple sclerosis lesion
Prineas, J. W., & Parratt, J. D. E. (2012) · Annals of Neurology · doi:10.1002/ana.23634 · Cited by 149 · see citing works
Nohria, V., & Giller, E. L. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2006.11.003 · Cited by 145 · see citing works
Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis
Garay, L. I., Deniselle, M. C. G., Lima, A. E., Roig, P., & Nicola, A. F. D. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.03.040 · Cited by 140 · see citing works
Pharmacokinetic and behavioral effects of allopregnanolone in healthy women
Timby, E., Balgård, M., Nyberg, S., Spigset, O., Andersson, A., Porankiewicz, J., Purdy, R. H., Zhu, D., Bäckström, T. C., & Poromaa, I. S. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0148-7 · Cited by 134 · see citing works
Singh, C., Liu, L., Wang, J. M., Irwin, R. W., Yao, J., Chen, S., Henry, S., Thompson, R. F., & Brinton, R. D. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.06.008 · Cited by 129 · see citing works
Reyes-García, M. G., Hernández, F. H., Hernández‐Téllez, B., & García-Tamayo, F. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.05.013 · Cited by 121 · see citing works
Neurosteroids as Endogenous Inhibitors of Neuronal Cell Apoptosis in Aging
Charalampopoulos, I., Alexaki, V. I., Tsatsanis, C., MINAS, V., Dermitzaki, E., Lazaridis, I., Vardouli, L., Stournaras, C., Margioris, A. N., Castanas, E., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1366.003 · Cited by 113 · see citing works
Abourbeh, G., Thezé, B., Maroy, R., Dubois, A., Brulon, V., Fontyn, Y., Dollé, F., Tavitian, B., & Boisgard, R. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2900-11.2012 · Cited by 112 · see citing works
Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis
Kipp, M., & Beyer, C. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.04.004 · Cited by 108 · see citing works
Clinical Evaluation of Ganaxolone in Pediatric and Adolescent Patients with Refractory Epilepsy
Pieribone, V. A., Tsai, J., Soufflet, C., Rey, E., Shaw, K., Giller, E. L., & Dulac, O. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01182.x · Cited by 107 · see citing works
Irwin, R. W., & Brinton, R. D. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.08.004 · Cited by 106 · see citing works
Neurosteroids reduce inflammation after TBI through CD55 induction
VanLandingham, J. W., Cekic, M. M., Cutler, S. M., Hoffman, S. W., & Stein, D. G. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.08.045 · Cited by 106 · see citing works
Different Subtypes of GABA-A Receptors Are Expressed in Human, Mouse and Rat T Lymphocytes
Mendu, S. K., Bhandage, A. K., Jin, Z., & Birnir, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042959 · Cited by 105 · see citing works
Alzheimer?s disease: the impact of age-related changes in reproductive hormones
Simpkins, J. W., Yang, S., Wen, Y., & Singh, M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4382-2 · Cited by 96 · see citing works
Mead, E., Mosley, A. J., Eaton, S. D., Dobson, L., Heales, S., & Pocock, J. M. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07659.x · Cited by 86 · see citing works
Steroid hormones in multiple sclerosis
El‐Etr, M., Vukusic, S., Gignoux, L., Durand‐Dubief, F., Achiti, I., Baulieu, E. E., & Confavreux, C. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.004 · Cited by 79 · see citing works
Axonal Regeneration and Neuroinflammation: Roles for the Translocator Protein 18 kDa
Girard, C., Liu, S., Adams, D., Lacroix, C., Sinéus, M., Boucher, C., Papadopoulos, V., Rupprecht, R., Schumacher, M., & Groyer, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02215.x · Cited by 75 · see citing works
The 18 kDa Translocator Protein (TSPO): A New Perspective in Mitochondrial Biology
Gatliff, J., & Campanella, M. (2012) · Current Molecular Medicine · doi:10.2174/1566524011207040356 · Cited by 74 · see citing works
Nothdurfter, C., Rammes, G., Baghai, T. C., Schüle, C., Schumacher, M., Papadopoulos, V., & Rupprecht, R. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02166.x · Cited by 71 · see citing works
Zhao, Y., Yu, J., Li, Q., Ma, C., Lü, C., & Xiao, B. (2011) · Neuron Glia Biology · doi:10.1017/s1740925x12000129 · Cited by 65 · see citing works
Effect of Oral Contraceptives on Experimental Demyelinating Disease
Arnason, B. G. W., & Richman, D. P. (1969) · Archives of Neurology · doi:10.1001/archneur.1969.00480130117012 · Cited by 65 · see citing works
Paul, A. M., Branton, W. G., Walsh, J. G., Polyak, M. J., Lu, J., Baker, G. B., & Power, C. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.037 · Cited by 54 · see citing works
Self-citationAdeosun, S. O., Hou, X., Jiao, Y., Zheng, B., Henry, S., Hill, R., He, Z., Pani, A. K., Kyle, P. B., Ou, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050040 · Cited by 54 · see citing works
Leaver, K. R., Reynolds, A. J., Bodard, S., Guilloteau, D., Chalon, S., & Kassiou, M. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200099e · Cited by 48 · see citing works
Baulieu, E.-E., & Schumacher, M. (1997) · Multiple Sclerosis Journal · doi:10.1177/135245859700300209 · Cited by 43 · see citing works
RON‐regulated innate immunity is protective in an animal model of multiple sclerosis
Tsutsui, S., Noorbakhsh, F., Sullivan, A., Henderson, A. J., Warren, K. G., Toney‐Earley, K., Waltz, S. E., & Power, C. (2005) · Annals of Neurology · doi:10.1002/ana.20502 · Cited by 39 · see citing works
Self-citationEffects of allopregnanolone on sedation in men, and in women on oral contraceptives
van Broekhoven, F., Bäckström, T. C., van Luijtelaar, G., Buitelaar, J. K., Smits, P., & Verkes, R. J. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.03.009 · Cited by 37 · see citing works
Sur, C., & Atack, J. R. (2003) · Humana Press eBooks · doi:10.1385/1-59259-118-3:39 · Cited by 36 · see citing works
Moralı́, G., Montes, P., Hernández-Morales, L., Monfil, T., Espinosa‐García, C., & Cervantes, M. (2011) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2011-0571 · Cited by 35 · see citing works
Müller, E., & Kerschbaum, H. (2006) · PubMed · Cited by 35 · see citing works
Hormonal Influences in Multiple Sclerosis
Shuster, E. A. (2007) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-73677-6_11 · Cited by 29 · see citing works
Singh, S., Hota, D., Prakash, A., KHANDUJA, K. L., Arora, S. K., & Chakrabarti, A. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.10.003 · Cited by 28 · see citing works
Ghezzi, P., Santo, E. D., Sacco, S., Foddi, C., Barbaccia, M. L., & Mennini, T. (2000) · PubMed · Cited by 27 · see citing works
Anticonvulsant action of allopregnanolone in immature rats
Mareš, P., Mikulecká, A., Haugvicová, R., & Kasal, A. (2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.03.009 · Cited by 23 · see citing works
Diehlmann, A., Ida, N., Weggen, S., Grünberg, J., Haass, C., Masters, C. L., Bayer, T. A., & Beyreuther, K. T. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990515)56:4 · Cited by 21 · see citing works
Patterson, M. C., & Pentchev, P. G. (1996) · Neurology · doi:10.1212/wnl.46.6.1785-b · Cited by 20 · see citing works
Anticonvulsant Action of a New Analogue of Allopregnanolone in Immature Rats
Mareš, P., Kubová, H., & Kasal, A. (2010) · Physiological Research · doi:10.33549/physiolres.931754 · Cited by 19 · see citing works
Effects of neurosteroids on neuronal survival: Molecular basis and clinical perspectives
Leśkiewicz, M., Budziszewska, B., Basta‐Kaim, A., Zając, A., Kaciński, M., & Lason, A. (2006) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2006-1624 · Cited by 17 · see citing works
Arnason, B. G. W., & Richman, D. P. (1969) · PubMed · Cited by 16 · see citing works
Olsen, R. W., & Li, G.-D. (2013) · Encyclopedia of Biological Chemistry · doi:10.1016/b978-0-12-378630-2.00339-x · Cited by 11 · see citing works
Flagged first, then by citations
4 of the 76 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,294 · see citing works
Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond
Zorumski, C. F., Paul, S. M., Covey, D. F., & Mennerick, S. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100196 · Cited by 305 · see citing works
Role of Estrogen and Other Sex Hormones in Brain Aging. Neuroprotection and DNA Repair
Zárate, S., Stevnsner, T., & Gredilla, R. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00430 · Cited by 286 · see citing works
Impact of sex hormones on immune function and multiple sclerosis development
Ysrraelit, M. C., & Correale, J. D. (2018) · Immunology · doi:10.1111/imm.13004 · Cited by 253 · see citing works
Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trials
Stein, D. G. (2015) · Brain Injury · doi:10.3109/02699052.2015.1065344 · Cited by 249 · see citing works
Neurosteroids as regulators of neuroinflammation
Yılmaz, C., Karali, K., Fodelianaki, G., Gravanis, A., Chavakis, T., Charalampopoulos, I., & Alexaki, V. I. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100788 · Cited by 245 · see citing works
Progesterone in the Brain: Hormone, Neurosteroid and Neuroprotectant
Guennoun, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155271 · Cited by 167 · see citing works
Crowley, T., Cryan, J. F., Downer, E. J., & O’Leary, O. F. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.02.001 · Cited by 150 · see citing works
Balan, I. S., Beattie, M. C., O’Buckley, T. K., Aurelian, L., & Morrow, A. L. (2019) · Scientific Reports · doi:10.1038/s41598-018-37409-6 · Cited by 118 · see citing works
Allopregnanolone: An overview on its synthesis and effects
Diviccaro, S., Cioffi, L., Falvo, E., Giatti, S., & Melcangi, R. C. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12996 · Cited by 110 · see citing works
Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways
Cano, A. C., Fonseca, E., Ettcheto, M., Sánchez‐López, E., de Rojas, I., Alonso-Lana, S., Morató, X., Souto, E. B., Toledo, M., Boada, M., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14101057 · Cited by 83 · see citing works
Irwin, R. W., Solinsky, C. M., & Brinton, R. D. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00203 · Cited by 72 · see citing works
Pleiotropic actions of allopregnanolone underlie therapeutic benefits in stress-related disease
Boero, G., Porcu, P., & Morrow, A. L. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100203 · Cited by 62 · see citing works
Pregnancy, postpartum and parity: Resilience and vulnerability in brain health and disease
Deems, N. P., & Leuner, B. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100820 · Cited by 63 · see citing works
Sex effects on inflammatory and neurodegenerative processes in multiple sclerosis
Ramien, C., Taenzer, A., Lupu, A., Heckmann, N., Engler, J. B., Patas, K., Friese, M. A., & Gold, S. M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.12.015 · Cited by 59 · see citing works
Hormonal Regulation of Oligodendrogenesis II: Implications for Myelin Repair
Breton, J., Long, K. L. P., Barraza, M., Perloff, O. S., & Kaufer, D. (2021) · Biomolecules · doi:10.3390/biom11020290 · Cited by 56 · see citing works
A Rationale for Allopregnanolone Treatment of Alcohol Use Disorders: Basic and Clinical Studies
Morrow, A. L., Boero, G., & Porcu, P. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14253 · Cited by 51 · see citing works
Nongenomic actions of neurosteroid pregnenolone and its metabolites
Weng, J., & Chung, B. (2016) · Steroids · doi:10.1016/j.steroids.2016.01.017 · Cited by 48 · see citing works
Schumacher, M., Guennoun, R., Mattern, C., Oudinet, J., Labombarda, F., Nicola, A. F. D., & Lière, P. (2015) · Steroids · doi:10.1016/j.steroids.2015.08.013 · Cited by 45 · see citing works
Role of Peripheral Immune Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
Dhaiban, S., Al‐Ani, M., Elemam, N. M., Al-Aawad, M. H., Al-Rawi, Z., & Maghazachi, A. A. (2021) · Sci · doi:10.3390/sci3010012 · Cited by 40 · see citing works
Steroid Sulfation in Neurodegenerative Diseases
Vítků, J., Hill, M., Kolátorová, L., Havrdová, E., & Kancheva, R. L. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.839887 · Cited by 40 · see citing works
Current status and future perspectives: TSPO in steroid neuroendocrinology
Selvaraj, V., & Tu, L. N. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0241 · Cited by 38 · see citing works
Enhanced remyelination during late pregnancy: involvement of the GABAergic system
Kalakh, S., & Mouihate, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-44050-4 · Cited by 38 · see citing works
Rustichelli, C., Bellei, E., Bergamini, S., Monari, E., Baraldi, C., Castro, F. L., Tomasi, A., & Ferrari, A. (2020) · Cephalalgia · doi:10.1177/0333102420937742 · Cited by 38 · see citing works
Sex steroid hormones as neuroprotective elements in ischemia models
Rubio, A. E. C., Pérez-Álvarez, M. J., Chala, C. L., & Wandosell, F. G. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0129 · Cited by 37 · see citing works
Avallone, R., Lucchi, C., Puja, G., Codeluppi, A., Filaferro, M., Vitale, G., Rustichelli, C., & Biagini, G. (2020) · Cells · doi:10.3390/cells9092091 · Cited by 36 · see citing works
Balan, I. S., Boero, G., Chéry, S. L., McFarland, M. H., Lopez, A. G., & Morrow, A. L. (2024) · Life · doi:10.3390/life14050582 · Cited by 33 · see citing works
Matrisciano, F., & Pinna, G. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100222 · Cited by 35 · see citing works
Intestinal Flora Affect Alzheimer's Disease by Regulating Endogenous Hormones
Wu, Y., Hang, Z., Tong, L., & Du, H. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03784-w · Cited by 34 · see citing works
The Hypothalamic-Pituitary-Ovarian Axis, Ovarian Disorders, and Brain Aging
Valera, H., Chen, A., & Grive, K. J. (2025) · Endocrinology · doi:10.1210/endocr/bqaf137 · Cited by 32 · see citing works
Balan, I. S., Aurelian, L., Williams, K. S., Campbell, B., Meeker, R. B., & Morrow, A. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.940095 · Cited by 32 · see citing works
Giatti, S., Diviccaro, S., Falvo, E., García‐Segura, L. M., & Melcangi, R. C. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100836 · Cited by 32 · see citing works
Morrow, A., Boero, G., & Balan, I. (2024) · Neuroscience and Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105558 · Cited by 25 · see citing works
New directions in neurosteroid therapeutics in neuropsychiatry
Zorumski, C. F., Covey, D. F., Izumi, Y., Evers, A. S., Maguire, J. L., & Mennerick, S. J. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106119 · Cited by 27 · see citing works
Effect of Pregnenolone vs Placebo on Self-reported Chronic Low Back Pain Among US Military Veterans
Naylor, J. C., Kilts, J. D., Shampine, L. J., Parke, G. J., Wagner, H. R., Szabo, S. T., Smith, K. D., Allen, T. B., Telford-Marx, E. G., Dunn, C. E., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.0287 · Cited by 26 · see citing works
Parks, E. E., Logan, S., Yeganeh, A., Farley, J. A., Owen, D. B., & Sonntag, W. E. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000479 · Cited by 26 · see citing works
Beattie, M. C., Maldonado‐Devincci, A. M., Porcu, P., O’Buckley, T. K., Daunais, J. B., Grant, K. A., & Morrow, A. L. (2015) · Addiction Biology · doi:10.1111/adb.12326 · Cited by 25 · see citing works
Short-term effects of diabetes on neurosteroidogenesis in the rat hippocampus
Romano, S., Mitro, N., Diviccaro, S., Spezzano, R., Audano, M., García‐Segura, L. M., Caruso, D., & Melcangi, R. C. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.11.019 · Cited by 25 · see citing works
Bannister, E. (2019) · Post Reproductive Health · doi:10.1177/2053369119875386 · Cited by 24 · see citing works
Chew, L., Sun, K., Sun, W., Wang, Z., Rajadas, J., Flores, R. E., Arnold, E., Jo, B., & Fung, L. K. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.105039 · Cited by 22 · see citing works
Rayatpour, A., Farhangi, S., Verdaguer, E., Olloquequi, J., Ureña, J. M., Auladell, C., & Javan, M. (2021) · Pharmaceuticals · doi:10.3390/ph14101031 · Cited by 19 · see citing works
A Narrative Review on Axonal Neuroprotection in Multiple Sclerosis
Collongues, N., Becker, G., Jolivel, V., Ayme-Dietrich, E., de Séze, J., Binamé, F., Patte-Mensah, C., Monassier, L., & Mensah-Nyagan, A. (2022) · Neurological Therapeutics · doi:10.1007/s40120-022-00363-7 · Cited by 16 · see citing works
Therapeutic effects of D-aspartate in a mouse model of multiple sclerosis
Afraei, S., D’Aniello, A., Sedaghat, R., Ekhtiari, P., Azizi, G., Tabrizian, N., Magliozzi, L., Aghazadeh, Z., & Mirshafiey, A. (2017) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2016.10.025 · Cited by 20 · see citing works
Orefice, N. S., Carotenuto, A., Mangone, G., Bues, B., Rehm, R., Cerillo, I., Saccà, F., Calignano, A., & Orefice, G. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.012 · Cited by 18 · see citing works
Human Microglia Synthesize Neurosteroids to Cope with Rotenone-Induced Oxidative Stress
Lucchi, C., Codeluppi, A., Filaferro, M., Vitale, G., Rustichelli, C., Avallone, R., Mandrioli, J., & Biagini, G. (2023) · Antioxidants · doi:10.3390/antiox12040963 · Cited by 17 · see citing works
Naylor, J. C., Kilts, J. D., Szabo, S. T., Dunn, C. E., Keefe, F. J., Tupler, L. A., Shampine, L. J., Morey, R. A., Strauss, J. L., Hamer, R. M., et al. (2015) · Pain Medicine · doi:10.1111/pme.12860 · Cited by 17 · see citing works
Tremolanti, C., Cavallini, C., Meyer, L., Klein, C., Pozzo, E. D., Costa, B., Germelli, L., Taliani, S., Patte‐Mensah, C., & Mensah‐Nyagan, A. G. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02737-2 · Cited by 16 · see citing works
The Impact of Gonadal Hormones on the Expression of Human Neurological Disorders
Schipper, H. M. (2015) · Neuroendocrinology · doi:10.1159/000440620 · Cited by 16 · see citing works
Servi, R., Akkoç, R. F., Aksu, F., & Servi, S. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106766 · Cited by 16 · see citing works
Targeting the Immune System With Pharmacotherapy in Schizophrenia
Melbourne, J. K., Feiner, B., Rosen, C., & Sharma, R. P. (2017) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-017-0114-0 · Cited by 14 · see citing works
Allopregnanolone suppresses glioblastoma survival through decreasing DPYSL3 and S100A11 expression
Feng, Y., Lim, S.-W., Lin, H., Wang, S., Hsu, S., Kao, T., Ko, C., & Hsu, T. (2022) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2022.106067 · Cited by 13 · see citing works
Izumi, Y., O’Dell, K. A., Cashikar, A. G., Paul, S. M., Covey, D. F., Mennerick, S. J., & Zorumski, C. F. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304481 · Cited by 12 · see citing works
Increased Serum Levels of C21 Steroids in Female Patients With Multiple Sclerosis
Kančeva, R., Stárka, L., Kancheva, L., Hill, M., Velíková, M., & Havrdová, E. (2015) · Physiological Research · doi:10.33549/physiolres.933145 · Cited by 11 · see citing works
Cadeddu, R., Mosher, L. J., Nordkild, P., Gaikwad, N. W., Ratto, G. M., Scheggi, S., & Bortolato, M. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100489 · Cited by 10 · see citing works
Wang, T., Chen, S., Mao, Z., Shang, Y., & Brinton, R. D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1286931 · Cited by 8 · see citing works
Altered Steroidome in Women with Multiple Sclerosis
Kancheva, R. L., Hill, M., Velíková, M., Kancheva, L. S., Včelák, J., Ampapa, R., Židó, M., Štětkářová, I., Libertínová, J., Vosátková, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212033 · Cited by 8 · see citing works
Neurosteroids Involvement in the Epigenetic Control of Memory Formation and Storage
Colciago, A., & Magnaghi, V. (2016) · Neural Plasticity · doi:10.1155/2016/5985021 · Cited by 8 · see citing works
Mifflin, K. A., Baker, G. B., & Kerr, B. J. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.08.040 · Cited by 8 · see citing works
Self-citationThe protective role of interaction between vitamin D, sex hormones and calcium in multiple sclerosis
Haghmorad, D., Soltanmohammadi, A., Tavaf, M. J., Zargarani, S., Yazdanpanah, E., Shadab, A., & Yousefi, B. (2022) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2147431 · Cited by 9 · see citing works
Mancino, D. N., Leicaj, M. L., Lima, A. E., Roig, P., Guennoun, R., Schumacher, M., Nicola, A. F. D., & Garay, L. I. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105820 · Cited by 7 · see citing works
Schoretsanitis, G., Osborne, L. M., Poromaa, I. S., Wenzel, E., Payne, J. L., Barbui, C., Gastaldon, C., & Deligiannidis, K. M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02747-7 · Cited by 8 · see citing works
Disability progression in multiple sclerosis is associated with plasma neuroactive steroid profile
Cheng, C. C., Gómez, D., McCombe, J. A., Smyth, P. S., Giuliani, F., Blevins, G., Baker, G. B., & Power, C. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05203-4 · Cited by 7 · see citing works
Self-citationMatta, C., Meyer, L., Mensah‐Nyagan, A. G., & Taleb, O. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00176-2 · Cited by 7 · see citing works
Neurosteroids and neurological disorders
Park, G., Kim, H., Won, S., Kim, N. H., & Choi, S. (2025) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.24.353 · Cited by 6 · see citing works
Rat Ovarian Function Is Impaired during Experimental Autoimmune Encephalomyelitis
Milosevic, A., Lavrnja, I. C., Savić, D. Z., Milosevic, K., Škuljec, J., Bjelobaba, I. M., & Janjic, M. M. (2023) · Cells · doi:10.3390/cells12071045 · Cited by 6 · see citing works
Toker, D., Chiang, J. N., Vespa, P. M., Caroline Schnakers, A., & Monti, M. M. (2025) · Neurocritical Care · doi:10.1007/s12028-025-02217-0 · Cited by 5 · see citing works
Effects of GABAergic Agents on Multiple Sclerosis. A Narrative Review of In-vivo Models
Stamoula, Ε., Ainatzoglou, A., Dardalas, I., Vavilis, T., Stamatellos, V., Siafis, S., Psathas, T., Boskou, I., & Papazisis, G. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666221003091444 · Cited by 5 · see citing works
Akkerman, V., Reinholdt, P., Schnoor-Madsen, R., Lauritsen, L., Bader, J., Qian, M., Xu, Y., Akk, G., Scheidt, H. A., Müller, P., et al. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00571 · Cited by 4 · see citing works
Goudarzvand, M., Panahi, Y., Yazdani, R., Miladi, H., Tahmasebi, S., Sherafat, A., Afraei, S., Abouhamzeh, K., Jamee, M., Al‐Hussieni, K. J. M. R., et al. (2018) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530318666181005093459 · Cited by 4 · see citing works
Sex Differences in Immunity and Inflammation: Implications for Brain and Behavior
Neigh, G. N., Nemeth, C. L., & Rowson, S. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802114-9.00001-9 · Cited by 4 · see citing works
Saleh, H., & Sadeghi, L. (2019) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2019_024 · Cited by 4 · see citing works
Amin, S. N., Abdalgeleel, S. A., Al‐Gahtany, M., Shaltout, S. A., Gazzar, W. B. E., & Elberry, D. A. (2021) · Brain Sciences · doi:10.3390/brainsci11050644 · Cited by 3 · see citing works
Multiple sclerosis lesions exhibit sex-specific steroid changes
Luchetti, S., Mason, M. R. J., Lière, P., Pianos, A., Cossu, S., Hofstee, M. I., Sluiter, A. A., Adelia, van Scheppingen, J., Aronica, E., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107040 · Cited by 2 · see citing works
Synthesis of a New Bioconjugate Steroid Pyridinium Salt Derived from Allopregnanolone Acetate
Rodríguez‐Matsui, H., Sánchez-Juárez, J. L., Tellez, V. C., Terán, J. L., Sandoval-Ramı́rez, J., & Carrasco‐Carballo, A. (2025) · Molbank · doi:10.3390/m2050 · Cited by 2 · see citing works
Трофимов, А. Н., Shcherbakova, K., Schwarz, A. P., Akbay, B., Karapina, O., Myrkhiyeva, Z., Shirokov, E., Kizatov, B., Zhukanov, K., Baktursyn, A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156606 · Cited by 3 · see citing works
Sex steroids, neurosteroidogenesis, and inflammation in multiple sclerosis and related animal models
Garay, L. I., Meyer, M., Guennoun, R., Schumacher, M., Deniselle, M. C. G., & Nicola, A. F. D. (2021) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2021.100286 · Cited by 2 · see citing works
Sherer, M. L., Malik, A., Osborne, L. M., Rowther, A. A., Zaidi, A., Atif, N., Rahman, A., Kahloon, L. E., Salman, M., Yenokyan, G., et al. (2022) · JMIR Research Protocols · doi:10.2196/43193 · Cited by 2 · see citing works
Pérez‐Osorio, I. N., Espinosa, A., Álvarez-Gutiérrez, C., González-Flores, R., Besedovsky, H. O., Fragoso, G., Torres-Ramos, M., & Sciutto, E. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2912420 · Cited by 1 · see citing works
Effect of Treatment on Steroidome in Women with Multiple Sclerosis
Hill, M., Kancheva, R. L., Velíková, M., Kancheva, L., Včelák, J., Ampapa, R., Židó, M., Štětkářová, I., Libertínová, J., Vosátková, M., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051835 · Cited by 1 · see citing works
Neuroactive Steroids and Related Steroids in Autism Spectrum Disorders
Zheng, H. F., Wang, W. Q., Li, X. M., Rauw, G. A., MellAAdo, J. M. L., & Baker, G. B. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000368 · Cited by 1 · see citing works
Self-citationTraish, A. M. (2015) · Current Sexual Health Reports · doi:10.1007/s11930-015-0061-y · Cited by 1 · see citing works
Editorial on “New perspectives in neurosteroids action: a special player allopregnanolone”
Magnaghi, V., & Puia, G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00133 · Cited by 1 · see citing works
Neurosteroids and the Nervous System: From Physiology to Pathology
Talebi, F., & Noorbakhsh, F. (2015) · The Neuroscience Journal of Shefaye Khatam · doi:10.18869/acadpub.shefa.3.3.87
Self-citationNeuroactive Steroids and Neuroinflammation
Giatti, S., & Melcangi, R. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801914-6.00014-3
Sex-Related Factors in Multiple Sclerosis
Gold, S. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801914-6.00007-6
Chung, B. Y. T. (2018) · The Atrium (University of Guelph)
Sex Hormones as Risk Factors for Dementia
Mante, P. K., & Adomako, N. O. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_4
Ozcan, E., Akduman, R. C., Eyüpoglu, S., Bingöl, A., Ekmekçi, Ö. B., & Hatipoğlu, E. (2023) · Neurological Research · doi:10.1080/01616412.2023.2258040
Sex hormones and diseases of the nervous system
Schipper, H. M. (2025) · Brain medicine : · doi:10.61373/bm025w.0008
Steroidomic Changes in the Cerebrospinal Fluid of Women with Multiple Sclerosis
Kancheva, R. L., Havrdová, E., Velíková, M., Kancheva, L. S., Včelák, J., Ampapa, R., Židó, M., Štětkářová, I., Škodová, T., & Hill, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125904
Epilepsy associated with multiple sclerosis (сurrent state of the problem)
Vasilenko, A. F., Евгеньевна, Д. В., & Голдобин, В. В. (2025) · Medical alphabet · doi:10.33667/2078-5631-2025-32-30-34
Raafat, M. A., Al-Hasnaawei, S., Mousa, H. M., Malathi, H., Sahu, S., Prathiba, S., Singh, G., & Sinha, A. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70673
Han, X., Li, W., Huang, Y., Wang, L., Zhao, T., Chen, X., Lin, H., Wang, Y., Ge, R., & Ma, J. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.112186
Porcu, P., Serra, M., Pisanu, A., Pisu, M. G., & Fattore, L. (2026) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2026.101266
Tahmin, C. I., Kim, J., Corbin, C., Bracewell, D., Cook, M. D., Chekouo, T., & Fonkoue, I. T. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101324
- Authors
- Noorbakhsh, F., Baker, G. B., & Power, C.
- Affiliations
- Tehran University of Medical Sciences (IR)
- University of Alberta (CA)
- Corresponding author
- Noorbakhsh, Farshid
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2014-06-03
- Volume
- 8
- Pages
- 134-134
- ISSN
- 1662-5102 (ISSN-L)
- PMC
- PMC4042158
- OpenAlex
- W2115574860
- Cited by
- 95
- References
- 76
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 7 · 2023: 4 · 2022: 11 · 2021: 9 · 2020: 10 · 2019: 8 · 2018: 7 · 2017: 3 · 2016: 9 · 2015: 10 · 2014: 1
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Cellular Neuroscience (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Multiple Sclerosis Society of Canada
- Multiple Sclerosis Society
- Alberta Innovates
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- allopregnanolone, neuroinflammation, multiple sclerosis, neurosteroids, GABAA receptor, neuroprotection, autoimmune demyelination, leukocyte biology, neurodegenerative diseases, neurosteroidogenesis, glial cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review